Prof. Dr. Serkan Özakbaş (İzmir Hospital) – MPHCTC

Neurology

Prof. Dr. Serkan Özakbaş (İzmir Hospital)

Email Address serkan.ozakbas@mph.com.tr

Experience and Education

Residency in Medicine, Dokuz Eylül University Faculty of Medicine, 1994-1999

Bachelor’s Degree, Dokuz Eylül University Faculty of Medicine, 1986-1992

Research Interests

Multiple sclerosis

Neuroimmunology

Cognitive and psychosocial effects of neurological diseases

STUDY TYPE (EN)	LOCATION (EN)	COMPANY (EN)	BRANCH (EN)	INVESTIGATOR	PHASE (EN)	STUDY TITLE (EN)	STATUS (EN)	LINK (EN)
CLINICAL TRIAL	IZMIR MPH	NOVARTIS SAGLIK GIDA VE TARIM URUNLERI SAN. VE TIC. A.S.	NEUROLOGY	PROF DR SERKAN OZAKBAS	PHASE 3	A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension	ONGOING	https://clinicaltrials.gov/study/NCT04926818
CLINICAL TRIAL	IZMIR MPH	NOVARTIS SAGLIK GIDA VE TARIM URUNLERI SAN. VE TIC. A.S.	NEUROLOGY	PROF DR SERKAN OZAKBAS	PHASE 3	An Open-label, Single Arm, Multi-center Extension Study Evaluating Long-term Safety, Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis	ONGOING	https://clinicaltrials.gov/study/NCT03650114
CLINICAL TRIAL	IZMIR MPH	NOVARTIS SAGLIK GIDA VE TARIM URUNLERI SAN. VE TIC. A.S.	NEUROLOGY	PROF DR SERKAN OZAKBAS	PHASE 3	A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib	ONGOING	https://clinicaltrials.gov/study/NCT05156281
STUDY TYPE (EN)	LOCATION (EN)	COMPANY (EN)	BRANCH (EN)	INVESTIGATOR	PHASE (EN)	STUDY TITLE (EN)	STATUS (EN)	LINK (EN)